166 related articles for article (PubMed ID: 10596079)
1. [New vaccines against Bordetella Pertussis].
Eskola J; Mertsola J
Duodecim; 1996; 112(13):1137-8. PubMed ID: 10596079
[No Abstract] [Full Text] [Related]
2. New pertussis vaccination approaches: en route to protect newborns?
Locht C; Mielcarek N
FEMS Immunol Med Microbiol; 2012 Nov; 66(2):121-33. PubMed ID: 22574832
[TBL] [Abstract][Full Text] [Related]
3. Do we need a new vaccine to control the re-emergence of pertussis?
Mills KH; Ross PJ; Allen AC; Wilk MM
Trends Microbiol; 2014 Feb; 22(2):49-52. PubMed ID: 24485284
[TBL] [Abstract][Full Text] [Related]
4. Pertussis before and after the introduction of acellular pertussis vaccines in Finland.
Elomaa A; He Q; Minh NN; Mertsola J
Vaccine; 2009 Sep; 27(40):5443-9. PubMed ID: 19628060
[TBL] [Abstract][Full Text] [Related]
5. Using the Australian Childhood Immunisation Register to track the transition from whole-cell to acellular pertussis vaccines.
Torvaldsen S; Hull BP; McIntyre PB
Commun Dis Intell Q Rep; 2002; 26(4):581-3. PubMed ID: 12549528
[TBL] [Abstract][Full Text] [Related]
6. [Pertussis vaccines: acellular versus whole cell. Perhaps a return to the past?].
Cofré J
Rev Chilena Infectol; 2015 Oct; 32(5):559-63. PubMed ID: 26633113
[TBL] [Abstract][Full Text] [Related]
7. Is There a Need for a Stand-alone Acellular Pertussis Vaccine?
Heininger U
Pediatr Infect Dis J; 2018 Apr; 37(4):359-360. PubMed ID: 29189613
[No Abstract] [Full Text] [Related]
8. Risk factors for acellular and whole-cell pertussis vaccine failure in Senegalese children.
Lacombe K; Yam A; Simondon K; Pinchinat S; Simondon F
Vaccine; 2004 Dec; 23(5):623-8. PubMed ID: 15542182
[TBL] [Abstract][Full Text] [Related]
9. The cost of epidemiological transition: a study of a decrease in pertussis vaccination coverage.
Girard DZ
Health Policy; 2005 Nov; 74(3):287-303. PubMed ID: 15951048
[TBL] [Abstract][Full Text] [Related]
10. Acellular pertussis vaccines in Japan: past, present and future.
Watanabe M; Nagai M
Expert Rev Vaccines; 2005 Apr; 4(2):173-84. PubMed ID: 15889991
[TBL] [Abstract][Full Text] [Related]
11. Bordetella Pertussis infections in vaccinated and unvaccinated adolescents and adults, as assessed in a national prospective randomized Acellular Pertussis Vaccine Trial (APERT).
Ward JI; Cherry JD; Chang SJ; Partridge S; Keitel W; Edwards K; Lee M; Treanor J; Greenberg DP; Barenkamp S; Bernstein DI; Edelman R;
Clin Infect Dis; 2006 Jul; 43(2):151-7. PubMed ID: 16779740
[TBL] [Abstract][Full Text] [Related]
12. Licensed pertussis vaccines in the United States. History and current state.
Klein NP
Hum Vaccin Immunother; 2014; 10(9):2684-90. PubMed ID: 25483496
[TBL] [Abstract][Full Text] [Related]
13. Pertussis vaccine trials in the 1990s.
Lambert LC
J Infect Dis; 2014 Apr; 209 Suppl 1(Suppl 1):S4-9. PubMed ID: 24626871
[TBL] [Abstract][Full Text] [Related]
14. Improvements in the control of whooping cough.
Commun Dis Rep CDR Wkly; 1995 Jul; 5(30):143. PubMed ID: 7670582
[No Abstract] [Full Text] [Related]
15. [General immunogenesis after oral uptake of killed Pertussis bacteria].
Hof H; Finger H
Zentralbl Bakteriol Orig A; 1974; 227(1-4):282-8. PubMed ID: 4154597
[No Abstract] [Full Text] [Related]
16. A whooping cough booster shot is likely: who will get it? ...and an editorial view.
Child Health Alert; 2004 Sep; 22():1-2. PubMed ID: 15366123
[No Abstract] [Full Text] [Related]
17. [Prophylaxis of pertussis: development and use of acellular pertussis vaccine].
Chuprinina RP; Alekseeva IA; Ozeretskovskiĭ NA
Zh Mikrobiol Epidemiol Immunobiol; 2006; (1):99-105. PubMed ID: 16532655
[TBL] [Abstract][Full Text] [Related]
18. Lung pathology and immediate hypersensitivity in a mouse model after vaccination with pertussis vaccines and challenge with Bordetella pertussis.
Vandebriel RJ; Gremmer ER; Vermeulen JP; Hellwig SM; Dormans JA; Roholl PJ; Mooi FR
Vaccine; 2007 Mar; 25(12):2346-60. PubMed ID: 17224216
[TBL] [Abstract][Full Text] [Related]
19. The effect of changing from whole-cell to acellular pertussis vaccine on the epidemiology of hospitalized children with pertussis in Canada.
Bettinger JA; Halperin SA; De Serres G; Scheifele DW; Tam T
Pediatr Infect Dis J; 2007 Jan; 26(1):31-5. PubMed ID: 17195702
[TBL] [Abstract][Full Text] [Related]
20. High levels of antibody in adults three years after vaccination with a reduced antigen content diphtheria-tetanus-acellular pertussis vaccine.
McIntyre PB; Turnbull FM; Egan AM; Burgess MA; Wolter JM; Schuerman LM
Vaccine; 2004 Dec; 23(3):380-5. PubMed ID: 15530684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
